PI
BMY icon

PEAK6 Investments’s Bristol-Myers Squibb BMY Stock Holding History

PEAK6 Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$12.8M Buy
246,900
+215,500
+686% +$10.1M 0.03% 469
2024
Q2 		$1.3M Buy
31,400
+5,400
+21% +$242K ﹤0.01% 1644
2024
Q1 		$1.41M Buy
26,000
+1,000
+4% +$50.9K ﹤0.01% 1683
2023
Q4 		$1.28M Sell
25,000
-50,000
-67% -$2.62M ﹤0.01% 1875
2023
Q3 		$4.35M Buy
75,000
+43,200
+136% +$2.65M 0.02% 795
2023
Q2 		$2.03M Sell
31,800
-27,600
-46% -$1.85M 0.01% 1182
2023
Q1 		$4.12M Sell
59,400
-632,500
-91% -$44.6M 0.02% 828
2022
Q4 		$49.8M Buy
691,900
+454,100
+191% +$34.2M 0.29% 52
2022
Q3 		$16.9M Sell
237,800
-1,112,000
-82% -$80.7M 0.07% 264
2022
Q2 		$104M Sell
1,349,800
-737,700
-35% -$56.2M 0.2% 69
2022
Q1 		$152M Buy
2,087,500
+1,136,200
+119% +$76.3M 0.32% 45
2021
Q4 		$59.3M Buy
951,300
+623,000
+190% +$36.5M 0.13% 149
2021
Q3 		$19.4M Sell
328,300
-57,700
-15% -$3.8M 0.04% 404
2021
Q2 		$25.8M Buy
386,000
+215,200
+126% +$14M 0.06% 287
2021
Q1 		$10.8M Sell
170,800
-545,600
-76% -$33.9M 0.03% 604
2020
Q4 		$44.4M Sell
716,400
-133,300
-16% -$8.2M 0.09% 189
2020
Q3 		$51.2M Sell
849,700
-163,600
-16% -$9.85M 0.13% 142
2020
Q2 		$59.6M Sell
1,013,300
-47,400
-4% -$2.84M 0.21% 86
2020
Q1 		$59.1M Buy
1,060,700
+970,600
+1,077% +$59.3M 0.35% 46
2019
Q4 		$5.78M Sell
90,100
-299,800
-77% -$17.2M 0.03% 567
2019
Q3 		$19.6M Buy
389,900
+305,300
+361% +$14.3M 0.12% 163
2019
Q2 		$3.84M Sell
84,600
-62,300
-42% -$2.9M 0.03% 860
2019
Q1 		$7.01M Sell
146,900
-142,600
-49% -$7.1M 0.04% 529
2018
Q4 		$15M Buy
289,500
+108,500
+60% +$5.83M 0.1% 220
2018
Q3 		$11.2M Buy
+181,000
New +$10.7M 0.05% 415

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6 Investments's BMY Position: Q3 2024 in Review

PEAK6 Investments reduced its Bristol-Myers Squibb (BMY) stake by 10% in Q3 2024, selling an estimated $639K and leaving 120,168 shares worth $6.22M. The position accounts for 0.01% of the portfolio, ranked #820.

PEAK6 Investments first reported a position in BMY in Q4 2018 and has held it in 19 quarters since. The position peaked at $21.5M in Q1 2021. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • PEAK6 Investments held 120,168 shares of Bristol-Myers Squibb worth $6.22M as of Q3 2024.
  • PEAK6 Investments sold 13,618 Bristol-Myers Squibb shares in Q3 2024, an estimated $639K.
  • Bristol-Myers Squibb made up 0.01% of PEAK6 Investments's portfolio in Q3 2024, its #820 holding.
  • PEAK6 Investments first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 19 quarters since.
  • PEAK6 Investments's Bristol-Myers Squibb position peaked at $21.5M in Q1 2021.
  • 2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.